SKINBIOTHERAPEUTICS PLC Logo

SKINBIOTHERAPEUTICS PLC

A life science company developing microbiome-based skin health products and supplements.

SBTX | IL

Overview

Corporate Details

ISIN(s):
GB00BF33H870
LEI:
213800YMQOCB23FX6I06
Country:
United Kingdom
Address:
THE CORE, NE4 5TF NEWCASTLE UPON TYNE
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

SkinBioTherapeutics PLC is a life science company advancing skin health through microbiome science. Its core activities center on the proprietary SkinBiotix® platform, a technology from The University of Manchester that harnesses the microbiome to protect and restore skin. The company commercializes its technology via in-house product development, such as the AxisBiotix probiotic food supplement for psoriasis, and through strategic acquisitions. Its subsidiaries, including Dermatonics and Bio-Tech Solutions, provide established product lines in dermatological and foot care, as well as formulation, manufacturing, and packaging services. SkinBioTherapeutics targets applications across five key sectors: Cosmetics, Food Supplements, Medical Devices, Hygiene, and Pharmaceuticals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 08:25
Major Shareholding Notification
Holding(s) in Company
English 50.6 KB
2025-11-19 08:25
Major Shareholding Notification
Holding(s) in Company
English 50.6 KB
2025-11-04 16:55
Major Shareholding Notification
Holding(s) in Company
English 50.6 KB
2025-10-14 08:00
Board/Management Information
Directorate Change
English 12.2 KB
2025-10-13 16:31
Major Shareholding Notification
Holding(s) in Company
English 22.2 KB
2025-10-13 16:30
Major Shareholding Notification
Holding(s) in Company
English 52.3 KB
2025-10-01 17:30
Major Shareholding Notification
Holding(s) in Company
English 51.9 KB
2025-08-14 08:00
Earnings Release
FY Trading Update
English 21.6 KB
2025-06-30 08:00
Regulatory News Service
Croda Commercial Launch Progressing as Expected
English 16.2 KB
2025-06-27 08:00
Regulatory News Service
Notice of IMC Shareholder Presentation
English 15.4 KB
2025-06-25 12:28
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-06-20 08:00
Share Issue/Capital Change
Result of WRAP Retail Offer
English 28.1 KB
2025-04-07 18:34
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-03-26 08:00
Earnings Release
Half-year Report
English 194.4 KB
2025-02-26 10:00
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB

Automate Your Workflow. Get a real-time feed of all SKINBIOTHERAPEUTICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SKINBIOTHERAPEUTICS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SKINBIOTHERAPEUTICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom
QBT
Read Gene Spolka Akcyjna Logo
Develops DNA tests to identify genetic cancer risk for early detection and prevention.
Poland
RDG
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland
RLF
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland
RVU
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom
SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom
SCLP
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom
SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland
SLV
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden
SIMRIS
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden
TERRNT

Talk to a Data Expert

Have a question? We'll get back to you promptly.